Abstract
Many studies have been recently performed on the activity of the enzyme superoxide dismutase (SOD) in tumor cells. This enzyme catalyzes the reaction \(\\{20_2}^{\bar .}\; + \;2H\; \to {H_2}{0_2}\; + \;{0_2}\;(1)\). SOD is thought to be a protective enzyme necessary for life in all oxygen metabolizing cells (2). All normal eukaryotic cells (except the red blood cell) have both copper-zinc containing superoxide dismutase activity (Cu-ZnSOD) and manganese containing superoxide dismutase activity (MnSOD) (3). A typical pattern has emerged from the studies of SOD in tumor cells. Cancer cells have in general lowered activities of both Cu-ZnSOD and MnSOD when compared to their differentiated normal cell counterparts. Exceptions have been found to this pattern of low Cu-ZnSOD activity, but no exceptions have been found in the case of MnSOD activity. MnSOD activity has been found to be greatly reduced in over 50 human, rat, mouse, spontaneous, transplanted, virallyinduced, chemically-induced, in vivo, and in vitro tumors. This work has been the subject of a recent review (4).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J.M. McCord, and I. Fridovich, J. Biol. Chem. 244, 6049 (1968).
J.M. McCord, B.B. Keele, and I. Fridovich, Proc. Natl. Acad. Sci USA, 68, 1024 (1971).
I. Fridovich, Adv. Enzymol., 41, 35 (1974).
L.W. Oberley, and G.R. Buettner, Cancer Res., 39, 1141 (1979).
N.G. Westman, and S.L. Marklund, Cancer Res., 41, 2962 (1981).
I.B. Bize, L.W. Oberley, and H.P. Morris, Cancer Res., 40, 3686, (1980).
D. Dionisi, T. Galeotti, T. Terranove, and A. Azzi, Biochim, Biophys. Acta, 403, 292 (1975).
L.W. Oberley, S.W.H.C. Leuthauser, G.R. Buettner, J.R.J. Sorenson, T.D. Oberley, and I.B. Bize, In: “Active Oxygen and Medicine”, A.P. Autor, Ed., Academic Press, New York (1982).
A. Petkau, W.S. Chelack, K. Kelly, C. Barefoot, and L. Monasterski, Res. Comm. Chem. Path. & Pharm., 17, 125 (1977).
S.W.C. Leuthauser, L.W. Oberley, T.D. Oberley, J.R.J. Sorenson, and K. Ramakrishna, J. Natl. Cancer Inst., 66, 1077 (1981).
L.R. DeAlvare, K. Goda, T. Kimura, Biochem. Biophys. Res. Commun., 69, 687 (1976).
L.W. Oberley, S.K. Sahu, J.R.J. Sorenson, unpublished observations.
S.W.C. Leuthauser, Ph.D. thesis, Univ. of Iowa, Dec. (1979).
R.F. Pasternack, and B. Halliwell, J. Am. Chem. Soc., 101, 1026 (1979).
R.F. Pasternack, and W.R. Skowronek, Jr., J. Inorgan. Biochem, 11, 261 (1979).
R.F. Pasternack, A. Banth, J.M. Pasternack, and C.S. Johnson, J. Inorg. Biochem, in press.
L.W. Oberley, S.W.C. Leuthauser, and R.F. Pasternack, to be submitted.
R.C. Jarnagin, and J.H. Wang, Am. Chem. Soc. J., 80, 6477, 1958.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 The Humana Press Inc.
About this chapter
Cite this chapter
Oberley, L.W., Leuthauser, S.W.C., Oberley, T.D., Sorenson, J.R.J., Pasternack, R.F. (1982). Antitumor SOD Compounds. In: Sorenson, J.R.J. (eds) Inflammatory Diseases and Copper. Experimental Biology and Medicine, vol 2. Humana Press. https://doi.org/10.1007/978-1-4612-5829-2_38
Download citation
DOI: https://doi.org/10.1007/978-1-4612-5829-2_38
Publisher Name: Humana Press
Print ISBN: 978-1-4612-5831-5
Online ISBN: 978-1-4612-5829-2
eBook Packages: Springer Book Archive